When it announced several months ago that it was shutting its doors but not closing down completely, Cincinnati biotech incubator BioStart said the show would go on — albeit in a different way. The show went on for a little while longer, but no more: BioStart will now cease all operations, according to a statement […]
A victim of changing medical device and drug company business models that have made its small wet laboratory space less relevant, Cincinnati incubator BioStart plans to close on September 30 after 15 years of operations. But president Carol Frankenstein says the BioStart show will go on, albeit in a different form. BioStart as an organization […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Some people see the limitations that are likely to be imposed through the nation's health care reform efforts, but Carol Frankenstein sees opportunities.
BIOSTART and Queen City Angels have formalized their long-standing relationship through a challenge: Jointly recruit 10 life sciences investors for the angel group within two years.
The life-science incubator BIOSTART has launched an initiative to attract and help about a half-dozen health-care services companies.
BIOSTART has entered into a partnership with YourEncore, which provides management and scientific advice as well as grant-writing help. In addition, BIOSTART in February created Dialedin.org, a life-science portal that lists current events, potential funding opportunities and expert advice.
Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more.
The state of Indiana used a $2 million to lure PDS Biotechnology, a Cincinnati-based company developing nanoparticle treatments to the immune system to prevent cancer, HPV and several other kinds of infections.